Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001140361-15-043725
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-04 17:50:34
Reporting Period:
2015-12-02
Filing Date:
2015-12-04
Accepted Time:
2015-12-04 17:50:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1416792 Relypsa Inc RLYP Pharmaceutical Preparations (2834) 260893742
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1477384 A John Orwin C/o Relypsa, Inc.
100 Cardinal Way
Redwood City CA 94063
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-02 20,000 $7.40 79,375 No 4 M Direct
Common Stock Disposition 2015-12-02 20,000 $25.00 59,375 No 4 S Direct
Common Stock Acquisiton 2015-12-04 20,000 $7.40 79,375 No 4 M Direct
Common Stock Disposition 2015-12-04 20,000 $25.00 59,375 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-12-02 20,000 $0.00 20,000 $7.40
Common Stock Stock Option (right to buy) Disposition 2015-12-04 20,000 $0.00 20,000 $7.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
757,877 2023-07-23 No 4 M Direct
737,877 2023-07-23 No 4 M Direct
Footnotes
  1. Includes 54,375 Restricted Stock Units.
  2. The sale reported in this Form 4 was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  3. The shares subject to the option are early exercisable. 25% of the shares subject to the option vest on the first anniversary measured from June 17, 2013 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.